Citation Impact
Citing Papers
Recurrent Fusion of TMPRSS2 and ETS Transcription Factor Genes in Prostate Cancer
2005 StandoutScience
Mutational landscape and significance across 12 major cancer types
2013 StandoutNature
Concordant Regulation of Gene Expression by Hypoxia and 2-Oxoglutarate-dependent Dioxygenase Inhibition
2006 StandoutNobel
Hallmarks of Cancer: The Next Generation
2011 Standout
The DNA-damage response in human biology and disease
2009 StandoutNature
Endogenous human microRNAs that suppress breast cancer metastasis
2008 StandoutNature
Cell mechanics and the cytoskeleton
2010 StandoutNature
Topoisomerase II as a target for anticancer drugs: When enzymes stop being nice
2000
[1] Measurement of absolute oxygen levels in cells and tissues using oxygen sensors and 2-nitroimidazole EF5
2002
Pilot study of epothilone B analog (BMS-247550) and estramustine phosphate in patients with progressive metastatic prostate cancer following castration
2003
Antineoplastic unsaturated fatty acids from Fijian macroalgae
2008
Bastadin 6, a spongean brominated tyrosine derivative, inhibits tumor angiogenesis by inducing selective apoptosis to endothelial cells
2006
Inflammation and cancer
2002 StandoutNature
mTOR Signaling in Growth Control and Disease
2012 Standout
A view on drug resistance in cancer
2019 StandoutNature
Genes that mediate breast cancer metastasis to the brain
2009 StandoutNature
Mechanism Targeted Discovery of Antitumor Marine Natural Products
2004
Oncogenic kinase signalling
2001 StandoutNature
Mediators of vascular remodelling co-opted for sequential steps in lung metastasis
2007 Nature
Ecological leads for natural product discovery: novel sesquiterpene hydroquinones from the red macroalga Peyssonnelia sp.
2009
Bromophycoic Acids: Bioactive Natural Products from a Fijian Red Alga Callophycus sp.
2012
Marine natural products
1990 Standout
Tumor angiogenesis: past, present and the near future
2000
Farnesyltransferase inhibitors: promises and realities
2002
Life in cellulose houses: symbiotic bacterial biosynthesis of ascidian drugs and drug leads
2010
Metabolism and action of amino acid analog anti-cancer agents
1990
Proliferation, cell cycle and apoptosis in cancer
2001 StandoutNature
Anticancer therapy with novel tubulin-interacting drugs
2001
Strategies for MMP inhibition in cancer: innovations for the post-trial era
2002
The Hedgehog and Wnt signalling pathways in cancer
2001 StandoutNature
Angiogenesis in cancer and other diseases
2000 StandoutNature
The Hallmarks of Cancer
2000 Standout
Oncogenic pathway signatures in human cancers as a guide to targeted therapies
2005 StandoutNature
Effective and selective targeting of leukemia cells using a TORC1/2 kinase inhibitor
2010
Radiosensitization by a new potent nucleoside analog: 1-(1′,3′,4′-trihydroxy-2′-butoxy)methyl-2-nitroimidazole(RP-343)
1993 StandoutNobel
Nuclear factor-κB in cancer development and progression
2006 StandoutNature
Angiogenesis in life, disease and medicine
2005 StandoutNature
The microenvironment of the tumour–host interface
2001 StandoutNature
Targeting RAS signalling pathways in cancer therapy
2003 Standout
Immunity, Inflammation, and Cancer
2010 Standout
The Genomic Response of Tumor Cells to Hypoxia and Reoxygenation
1995
Structure and biological evaluation of novel cytotoxic sterol glycosides from the marine red alga Peyssonnelia sp.
2010
Discovery of betulinic acid as a selective inhibitor of human melanoma that functions by induction of apoptosis
1995 Standout
Phosphoglycerate kinase acts in tumour angiogenesis as a disulphide reductase
2000 Nature
The causes and consequences of genetic heterogeneity in cancer evolution
2013 StandoutNature
Classification of anticancer drugs—a new system based on therapeutic targets
2003
Buthionine sulfoximine-mediated depletion of glutathione in intracranial human glioma-derived xenografts
1988 StandoutNobel
Control of TH17/Treg Balance by Hypoxia-Inducible Factor 1
2011 StandoutNobel
Small cell lung cancer: the importance of the extracellular matrix
2004
Microtubules as a target for anticancer drugs
2004 Standout
The Hallmarks of Aging
2013 Standout
Gold from the sea: Marine compounds as inhibitors of the hallmarks of cancer
2011
Metastatic colonization by circulating tumour cells
2016 StandoutNature
Investigations of the marine flora and fauna of the Fiji Islands
2012
Angiogenesis as a therapeutic target
2005 StandoutNature
Selection of Bone Metastasis Seeds by Mesenchymal Signals in the Primary Tumor Stroma
2013
Biosynthesis and function of polyacetylenes and allied natural products
2008
A Comparison of Cationic Zirconium Methyl and Isobutyl Initiators that Contain an Arylated Diamido-Pyridine Ligand for Polymerization of 1-Hexene. Elucidation of a Dramatic “Initiator Effect”
2000 StandoutNobel
Endogenous Inhibitors of Angiogenesis
2005
Chemical Topology: Complex Molecular Knots, Links, and Entanglements
2011 StandoutNobel
Callophycoic Acids and Callophycols from the Fijian Red Alga Callophycus serratus
2007
Resistance to Enediyne Antitumor Antibiotics by CalC Self-Sacrifice
2003 Science
Drug Discovery and Natural Products: End of an Era or an Endless Frontier?
2009 StandoutScience
Total synthesis of makaluvamine A/D, damirone B, batzelline C, makaluvone, and isobatzelline C featuring one-pot benzyne-mediated cyclization–functionalization
2012
Synthesis of Tetrahydropyrroloiminoquinone Alkaloids Based on Electrochemically Generated Hypervalent Iodine Oxidative Cyclization
2009
Antimalarial Activity of Pyrroloiminoquinones from the Australian Marine SpongeZyzzyasp.
2012
Makaluvic Acids A and B: Novel Alkaloids from the Marine Sponge Zyzzya fuliginosus
1996
Dasatinib, a small-molecule protein tyrosine kinase inhibitor, inhibits T-cell activation and proliferation
2007
Bromophycolides C−I from the Fijian Red Alga Callophycus serratus
2006
The development of imatinib as a therapeutic agent for chronic myeloid leukemia
2004
Antitumor Antibiotics: Bleomycin, Enediynes, and Mitomycin
2005 Standout
New alkaloids from a South African latrunculid sponge
1996
The Role of Glutathione in Copper Metabolism and Toxicity
1989
Rational Development of Practical Catalysts for Aromatic Carbon−Nitrogen Bond Formation
1998 Standout
Hypoxia-inducible Factor-1 Mediates Transcriptional Activation of the Heme Oxygenase-1 Gene in Response to Hypoxia
1997 StandoutNobel
A Perspective on Cancer Cell Metastasis
2011 StandoutScience
Genes and pathways downstream of telomerase in melanoma metastasis
2006 StandoutNobel
Enediyne Biosynthesis and Self-Resistance: A Progress Report
1999
Mechanism of Ascididemin-Induced Cytotoxicity
2003
Secobatzellines A and B, Two New Enzyme Inhibitors from a Deep-Water Caribbean Sponge of the Genus Batzella
1999
Cancer Immunoediting: Integrating Immunity’s Roles in Cancer Suppression and Promotion
2011 StandoutScience
Activation of AP-1 and of a nuclear redox factor, Ref-1, in the response of HT29 colon cancer cells to hypoxia.
1994
Utilizing the Power of Microbial Genetics to Bridge the Gap Between the Promise and the Application of Marine Natural Products
2005
Irradiation of a primary tumor, unlike surgical removal, enhances angiogenesis suppression at a distal site: potential role of host-tumor interaction.
2000
A Journey Under the Sea: The Quest for Marine Anti-Cancer Alkaloids
2011
Enzyme Inhibitors from Marine Invertebrates
2007
Anticancer activity of natural and synthetic acetylenic lipids
2006
Bioactive Bromophycolides R−U from the Fijian Red Alga Callophycus serratus
2010
Caulibugulones A−F, Novel Cytotoxic Isoquinoline Quinones and Iminoquinones from the Marine Bryozoan Caulibugula intermis
2004
Asymmetric Transfer Hydrogenation of α, β-Acetylenic Ketones
1997 StandoutNobel
UV-stability and UV-protective activity of alkaloids from the marine sponge Zyzzya fuliginosa
2006
Single-Cell Mass Cytometry of Differential Immune and Drug Responses Across a Human Hematopoietic Continuum
2011 StandoutScience
Normalization of Tumor Vasculature: An Emerging Concept in Antiangiogenic Therapy
2005 StandoutScience
Cytotoxic Pyrroloiminoquinones from Four New Species of South African Latrunculid Sponges
2004
Zyzzyanones B−D, Dipyrroloquinones from the Marine Sponge Zyzzya fuliginosa
2005
A new non-protein enediyne antibiotic N1999A2: Unique enediyne chromophore similar to neocarzinostatin and DNA cleavage feature
1998
Enzymatic aminoacylation of tRNA with unnatural amino acids
2006 StandoutNobel
Discorhabdin P, a New Enzyme Inhibitor from a Deep-Water Caribbean Sponge of the Genus Batzella
1998
Angiogenesis in Endocrine Tumors
2003
Chemotherapy triggers HIF-1–dependent glutathione synthesis and copper chelation that induces the breast cancer stem cell phenotype
2015 StandoutNobel
Genes Expressed in Human Tumor Endothelium
2000 StandoutScience
Discorhabdins from the Korean Marine Sponge Sceptrella sp.
2010
Synthesis of Group 4 Complexes that Contain the Diamidoamine Ligands, [(2,4,6-Me3C6H2NCH2CH2)2NR]2- ([Mes2N2NR]2-; R = H or CH3), and Polymerization of 1-Hexene by Activated [Mes2N2NR]ZrMe2 Complexes
1999 StandoutNobel
Parazoanthines A−E, Hydantoin Alkaloids from the Mediterranean Sea Anemone Parazoanthus axinellae
2009
Marmycins A and B, Cytotoxic Pentacyclic C-Glycosides from a Marine Sediment-Derived Actinomycete Related to the Genus Streptomyces
2007
Antimalarial Bromophycolides J−Q from the Fijian Red Alga Callophycus serratus
2009
Reduction of Dinitrogen to Ammonia at a Well-Protected Reaction Site in a Molybdenum Triamidoamine Complex
2002 StandoutNobel
Asymmetric Transfer Hydrogenation of Imines
1996 StandoutNobel
Works of Robert A. Kramer being referenced
BMS-754807, a small molecule inhibitor of insulin-like growth factor-1R/IR
2009
Pharmacodynamic analysis of target inhibition and tumor endothelial cell death in biopsies obtained from patients treated with the VEGF receptor antagonists SU5416 or SU6668
2004
Correlation of pharmacokinetics with the antitumor activity of Cetuximab in nude mice bearing the GEO human colon carcinoma xenograft
2005
Final report of the phase I trial of continuous infusion etanidazole (SR 2508): A radiation therapy oncology group study
1992
Distribution of etanidzole into human brain tumors: Implications for treating high grade gliomas
1992
Mechanism of Topoisomerase II Inhibition by Staurosporine and Other Protein Kinase Inhibitors
1996
Initial results of a phase i trial of continuous infusion SR 2508 (etanidazole): A radiation therapy oncology group study
1989
Chemical modifiers of cancer treatment.
1988
Selective Inhibition by Kringle 5 of Human Plasminogen on Endothelial Cell Migration, an Important Process in Angiogenesis
1998
Characterization of kringle domains of angiostatin as antagonists of endothelial cell migration, an important process in angiogenesis
1998
Role of the Glutathione Redox Cycle in Acquired and de Novo Multidrug Resistance
1988 Science
BMS-247550: a novel epothilone analog with a mode of action similar to paclitaxel but possessing superior antitumor efficacy.
2001
The mechanism of cancer-mediated conversion of plasminogen to the angiogenesis inhibitor angiostatin
1997
Makaluvamines, marine natural products, are active anti-cancer agents and DNA topo II inhibitors.
1993
Novel Strategies for the Discovery of Plant-Derived Anticancer Agents
2003
Novel cytotoxic topoisomerase II inhibiting pyrroloiminoquinones from Fijian sponges of the genus Zyzzya
1993
Conjugate addition of vinylcopper complexes derived from addition of alkylcopper complexes to acetylenes. A stereospecific synthesis of trisubstituted olefins
1977
Chemosensitization of L-phenylalanine mustard by the thiol-modulating agent buthionine sulfoximine.
1987
Inhibition of angiogenesis and metastasis in two murine models by the matrix metalloproteinase inhibitor, BMS-275291.
2001
Namenamicin, a New Enediyne Antitumor Antibiotic from the Marine Ascidian Polysyncraton lithostrotum
1996
Preclinical antitumor activity of BMS-214662, a highly apoptotic and novel farnesyltransferase inhibitor.
2001
Dasatinib (BMS-354825) Pharmacokinetics and Pharmacodynamic Biomarkers in Animal Models Predict Optimal Clinical Exposure
2006